![]() HONG KONG, July 8 (Reuters) - Chinese medical data group LinkDoc Technology Ltd (LDOC.O) has shelved plans for an IPO in the United States following Beijing's clampdown on overseas listings by domestic firms, according to three sources with direct knowledge of the matter. But Didi’s listing is probably going the last major IPO by a Chinese firm in the U.S. It is the first known Chinese firm to pull back from its IPO plans since the crackdown began last week with an investigation by China's cybersecurity regulator into ride-hailing giant Didi Global Inc (DIDI.N) just two days after it made its New York debut.īeijing said on Tuesday that it would strengthen supervision of all Chinese firms listed offshore, a sweeping regulatory shift that triggered a sell-off in U.S.-listed Chinese stocks. Two weeks ago, Chinese ride-hailing big Didi Chuxing debuted in New York and raised 4.4 billion. and liquid biopsy sources, including circulating tumor DNA (ctDNA). The decision to pull the LinkDoc deal was due to the crackdown, the sources said. treatment for HER2-positive breast cancer, has been investigated but did not show. One of the sources said the regulatory uncertainty affected both the company and investors. Tim has been a China-based contributor for publications including The Sunday Times. LinkDoc filed for an initial public offering in the United States last month and was due to price its shares after the U.S. ![]() trading session since Chinese regulators ordered its app off mobile app stores in China. Didi, which offers services in China and more than 15 international markets, gathers vast amounts of real-time mobility data every day. It had planned to sell 10.8 million shares between $17.50 and $19.50 each. July 8 - Medical data group LinkDoc Technology becomes the first Chinese company to pull back from plans to list in the United States after regulators started an investigation into Didi. One of the sources said the regulatory uncertainty affected both the company and investors. LinkDoc Technology, which is backed by Alibaba Health (BABA) filed, filed for an IPO to raise 100m, although that’s likely just a placeholder value.Medical data company LinkDoc wrote in. The deal would have raised $211 million at the upper end of the indicated range. LinkDoc filed for an initial public offering in the United States last month and was due to price its. The book closed one day earlier than planned on Wednesday, two of the sources said. The sources declined to be named as the information has not yet been made public yet.īeijing-based LinkDoc did not immediately respond to a request for comment.
0 Comments
Leave a Reply. |